# Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid Tumors

> **NCT02040558** · PHASE1 · TERMINATED · sponsor: **Mallinckrodt** · enrollment: 44 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** MNK-010

## Key facts

- **NCT ID:** NCT02040558
- **Lead sponsor:** Mallinckrodt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-07
- **Primary completion:** 2016-05
- **Final completion:** 2016-07
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2017-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02040558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02040558, "Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02040558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*